Stocks
Intellia Therapeutics (NTLA) ROE US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -34.3% | -23.8% | -25.0% | -39.7% | -45.8% | -54.3% | ||
| Changes by years, y/y, % | -4pp | +11pp | -1pp | -15pp | -6pp | +8.3% | |||
Intellia Therapeutics. ROE, %
Intellia Therapeutics. ROE, changes, pp
Intellia Therapeutics (NTLA) ROE US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROE, % | ? | -43.9% | -44.8% | -46.9% | -52.4% | -54.3% | -54.3% | |
| Changes by years, y/y, % | +10pp | -6pp | -12pp | -12pp | -10pp | |||
| Changes by quarters, q/q, % | -4pp | -1pp | -2pp | -6pp | -2pp | |||
